Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / People / Manuel Hidalgo
Person

Manuel Hidalgo

Tracked across 1 events · 74 articles · First seen Apr 15, 2026 · Last active Jun 04, 2026

Sentiment
70
Attention
7
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
7 70
Tech
Revolution_Medicines' daraxonrasib extends pancreatic cancer survival
Researchers have reported a significant breakthrough in treating advanced pancreatic cancer with an experimental pill called daraxonrasib, developed by Revolution Medicines. The daily pill nearly doubled the median survival time for patients whose metastatic cancer…
Impact: Manuel Hidalgo, director of NYU Grossman School of Medicine's Gastrointestinal Cancer Center, emphasized the drug's practice-changing potential and the need for further research into its efficacy across different genetic mutations.
May 29, 2026 · 74 articles
NEWSDESK
Track Manuel Hidalgo live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.